Blueprint Medicines Corp Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 9,166 | 340,150 | 82,500 | |
| Nov 24 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 70.00 | 9,166 | 641,620 | 0 | 9.2 K to 0 (-100.00 %) |
| Nov 24 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 9,166 | 340,150 | 9,166 | 0 to 9.2 K |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 18,334 | 680,375 | 91,666 | |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | S | 64.44 | 500 | 32,220 | 0 | -500 to 0 (-100.00 %) |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 65.16 | 11,483 | 748,232 | 500 | 12 K to 500 (-95.83 %) |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 65.81 | 4,750 | 312,598 | 11,983 | 16.7 K to 12 K (-28.39 %) |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 66.81 | 1,601 | 106,963 | 16,733 | 18.3 K to 16.7 K (-8.73 %) |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 18,334 | 680,375 | 18,334 | 0 to 18.3 K |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 5,874 | 95,629 | 95,985 | |
| Nov 22 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 5,874 | 95,629 | 5,874 | 0 to 5.9 K |
| Nov 17 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 62.59 | 1,200 | 75,108 | 204,342 | 205.5 K to 204.3 K (-0.58 %) |
| Nov 17 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 63.25 | 2,200 | 139,150 | 205,542 | 207.7 K to 205.5 K (-1.06 %) |
| Nov 17 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 64.15 | 1,600 | 102,640 | 207,742 | 209.3 K to 207.7 K (-0.76 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 8.80 | 5,000 | 44,000 | 169,544 | |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 69.59 | 2,380 | 165,624 | 0 | 2.4 K to 0 (-100.00 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 70.29 | 1,520 | 106,841 | 2,380 | 3.9 K to 2.4 K (-38.97 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 71.69 | 700 | 50,183 | 3,900 | 4.6 K to 3.9 K (-15.22 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 72.87 | 200 | 14,574 | 4,600 | 4.8 K to 4.6 K (-4.17 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 74.00 | 200 | 14,800 | 4,800 | 5 K to 4.8 K (-4.00 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 8.80 | 5,000 | 44,000 | 5,000 | 0 to 5 K |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 24,514 | 45,841 | 825,034 | |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 68.95 | 1,100 | 75,845 | 0 | 1.1 K to 0 (-100.00 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 69.74 | 16,469 | 1,148,548 | 1,100 | 17.6 K to 1.1 K (-93.74 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 70.40 | 7,432 | 523,213 | 17,569 | 25 K to 17.6 K (-29.73 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 71.67 | 2,600 | 186,342 | 25,001 | 27.6 K to 25 K (-9.42 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 72.91 | 1,999 | 145,747 | 27,601 | 29.6 K to 27.6 K (-6.75 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 73.89 | 400 | 29,556 | 29,600 | 30 K to 29.6 K (-1.33 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 24,514 | 45,841 | 30,000 | 5.5 K to 30 K (+446.85 %) |
| Nov 03 2017 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Option Exercise | A | 71.80 | 75,000 | 5,385,000 | 75,000 |